Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 11
Submit an article Journal homepage
449
Views
12
CrossRef citations to date
0
Altmetric
Letters to the Editor

STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)–STAT3 pathway

Amy BeltonHematology Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA;
,
Lingling XianHematology Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA;
,
Tait HusoHematology Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA;
,
Michael KooHematology Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA;
,
Li Z. LuoHematology Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA;
,
James TurksonCell and Molecular Biology Department, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA;
,
Brent D. G. PageDepartment of Chemistry, University of Toronto, Ontario, Canada;
,
Patrick T. GunningDepartment of Chemistry, University of Toronto, Ontario, Canada;
,
Guosheng LiuDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA;
,
David L. HusoDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; ;Department of Oncology, Institute for Cellular Engineering, the Johns Hopkins University School of Medicine, Baltimore, MD, USA
&
Linda M. S. ResarHematology Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; ;Department of Oncology, Institute for Cellular Engineering, the Johns Hopkins University School of Medicine, Baltimore, MD, USACorrespondence[email protected]
 show all
Pages 2681-2684 | Received 24 Nov 2015, Accepted 04 Feb 2016, Published online: 08 Mar 2016

References

  • Hunger SP, Loh ML, Whitlock JA, et al. Children's oncology group's 2013 blueprint for research: acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60:957–963.
  • Resar LM. The high mobility group A1 gene: transforming inflammatory signals into cancer? Cancer Res. 2010;70:436–439.
  • Wood LJ, Mukherjee M, Dolde CE, et al. HMG-I/Y, a new c-myc target gene and potential oncogene. Mol Cell Biol. 2000;20:5490–5502.
  • Xu Y, Sumter TF, Bhattacharya R, et al. The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia. Cancer Res. 2004;64:3371–3375.
  • Pedulla ML, Treff NR, Resar LMS, et al. Sequence and analysis of the murine Hmgiy (Hmga1). gene locus. Gene. 2001;271:51–58.
  • Hillion J, Dhara S, Sumter TF, et al. The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies? Cancer Res. 2008;68:10121–10127.
  • Schuldenfrei A, Belton A, Kowalski J, et al. HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis. BMC Genomics. 2011;12:549.
  • Di Cello F, Dhara S, Hristov AC, et al. Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis. Leuk Lymphoma. 2013;54:1762–1768.
  • Nelson DM, Joseph B, Hillion J, et al. Flavopiridol induces BCL-2 expression and represses oncogenic transcription factors in leukemic blasts from adults with refractory acute myeloid leukemia. Leuk Lymphoma. 2011;52:1999–2006.
  • Belton A, Gabrovsky A, Bae YK, et al. HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells. PLoS One. 2012;7:e30034.
  • Shah SN, Kerr C, Cope L, et al. HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks. PLoS One. 2012;7:e48533.
  • Somervaille TC, Matheny CJ, Spencer GJ, et al. Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell. 2009;4:129–140.
  • Roy S, Di Cello F, Kowalski J, et al. HMGA1 overexpression correlates with relapse in childhood B-lineage acute lymphoblastic leukemia. Leuk Lymphoma. 2013;54:2565–2567.
  • Hillion J, Di Cello F, Belton A, et al. Nanoparticle delivery of inhibitory signal transducer and activator of transcription 3 G-quartet oligonucleotides blocks tumor growth in HMGA1 transgenic model of T-cell leukemia. Leuk Lymphoma. 2014;55:1194–1197.
  • Zhang X, Yue P, Page BD, et al. Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts. Proc Natl Acad Sci USA. 2012;109:9623–9628.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.